177 related articles for article (PubMed ID: 36444378)
21. Assessment of metal concentrations in the SOD1
Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
[TBL] [Abstract][Full Text] [Related]
22. Muscle Fibers Secrete FGFBP1 to Slow Degeneration of Neuromuscular Synapses during Aging and Progression of ALS.
Taetzsch T; Tenga MJ; Valdez G
J Neurosci; 2017 Jan; 37(1):70-82. PubMed ID: 28053031
[TBL] [Abstract][Full Text] [Related]
23. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral Sclerosis.
Park KH
Aging Dis; 2015 Sep; 6(5):380-9. PubMed ID: 26425392
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of Enhanced Phrenic Long-Term Facilitation in
Nichols NL; Satriotomo I; Allen LL; Grebe AM; Mitchell GS
J Neurosci; 2017 Jun; 37(24):5834-5845. PubMed ID: 28500219
[TBL] [Abstract][Full Text] [Related]
26. Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1
Harrison JM; Rafuse VF
Neurobiol Dis; 2020 Nov; 145():105052. PubMed ID: 32827689
[TBL] [Abstract][Full Text] [Related]
27. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS).
Alhindi A; Boehm I; Chaytow H
J Anat; 2022 Nov; 241(5):1089-1107. PubMed ID: 34101196
[TBL] [Abstract][Full Text] [Related]
28. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
29. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion.
Vinsant S; Mansfield C; Jimenez-Moreno R; Del Gaizo Moore V; Yoshikawa M; Hampton TG; Prevette D; Caress J; Oppenheim RW; Milligan C
Brain Behav; 2013 Jul; 3(4):431-57. PubMed ID: 24381813
[TBL] [Abstract][Full Text] [Related]
30. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular junction degeneration in ALS.
Lynch EM; Robertson S; FitzGibbons C; Reilly M; Switalski C; Eckardt A; Tey SR; Hayakawa K; Suzuki M
Exp Neurol; 2021 Nov; 345():113815. PubMed ID: 34310943
[TBL] [Abstract][Full Text] [Related]
32. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS.
Gould TW; Buss RR; Vinsant S; Prevette D; Sun W; Knudson CM; Milligan CE; Oppenheim RW
J Neurosci; 2006 Aug; 26(34):8774-86. PubMed ID: 16928866
[TBL] [Abstract][Full Text] [Related]
33. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.
Sunyach C; Michaud M; Arnoux T; Bernard-Marissal N; Aebischer J; Latyszenok V; Gouarné C; Raoul C; Pruss RM; Bordet T; Pettmann B
Neuropharmacology; 2012 Jun; 62(7):2346-52. PubMed ID: 22369784
[TBL] [Abstract][Full Text] [Related]
34. A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1
Golko-Perez S; Amit T; Bar-Am O; Youdim MB; Weinreb O
Neurotox Res; 2017 Feb; 31(2):230-244. PubMed ID: 27826939
[TBL] [Abstract][Full Text] [Related]
35. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.
Zhang JJ; Zhou QM; Chen S; Le WD
CNS Neurosci Ther; 2018 Dec; 24(12):1163-1174. PubMed ID: 29656576
[TBL] [Abstract][Full Text] [Related]
36. Distinct transcriptomic profile of satellite cells contributes to preservation of neuromuscular junctions in extraocular muscles of ALS mice.
Li A; Yi J; Li X; Dong L; Ostrow LW; Ma J; Zhou J
bioRxiv; 2024 Apr; ():. PubMed ID: 36824725
[TBL] [Abstract][Full Text] [Related]
37. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
[TBL] [Abstract][Full Text] [Related]
38. Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis.
Rizzuto E; Pisu S; Musarò A; Del Prete Z
Ann Biomed Eng; 2015 Sep; 43(9):2196-206. PubMed ID: 25631208
[TBL] [Abstract][Full Text] [Related]
39. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
[TBL] [Abstract][Full Text] [Related]
40. Relationships between tongue motility, grip force, and survival in SOD1-G93A rats.
Smittkamp SE; Spalding HN; Brown JW; Yeh HW; Stanford JA
Physiol Behav; 2014 Feb; 125():17-20. PubMed ID: 24291387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
